Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • ADC Therapeutics' Depreciation & Amortization (CF) rose 104.27% to $335,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $1.3 million for FY2024, which is 12.38% up from last year.
  • Per ADC Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $1.3 million for FY2024, which was up 12.38% from $1.2 million recorded in FY2023.
  • ADC Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $1.3 million during FY2024, with a 5-year trough of $129,000 in FY2021.
  • In the last 3 years, ADC Therapeutics' Depreciation & Amortization (CF) had a median value of $1.2 million in 2023 and averaged $955,000.
  • In the last 5 years, ADC Therapeutics' Depreciation & Amortization (CF) surged by 776.67% in 2020 and then slumped by 50.95% in 2021.
  • ADC Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $263,000 in 2020, then plummeted by 50.95% to $129,000 in 2021, then soared by 166.67% to $344,000 in 2022, then spiked by 245.06% to $1.2 million in 2023, then grew by 12.38% to $1.3 million in 2024.